,Drug_bank_ID,Generic_names,Drug,Interacting Gene/Enzyme,Allele name,Genotypes,Defining change(s),Type(s),Description,Drug_application_number
0,DB00530,Erlotinib,Erlotinib,Epidermal growth factor receptorGene symbol: EGFRUniProt: P00533,G719A/C,(A;A) / (A;G) / (C;C) / (C;G) / (G;T) / (T;T),G > A or C or T (rs28929495),Effect Directly Studied,The presence of this polymorphism in EGFR is associated with a higher response rate to erlotinib.,NDA021743
1,DB00530,Erlotinib,Erlotinib,Epidermal growth factor receptorGene symbol: EGFRUniProt: P00533,L861Q,(A;A) / (A;T) / (G;G) / (G;T),T > A or G (rs121913444),Effect Directly Studied,The presence of this polymorphism in EGFR is associated with a higher response rate to erlotinib.,NDA021743
2,DB00530,Erlotinib,Erlotinib,Epidermal growth factor receptorGene symbol: EGFRUniProt: P00533,L858R,(G;G) / (G;T),T > G (rs121434568),Effect Directly Studied,The presence of this polymorphism in EGFR is associated with a higher response rate to erlotinib.,NDA021743
3,DB00002,Cetuximab,Cetuximab,Low affinity immunoglobulin gamma Fc region receptor II-aGene symbol: FCGR2AUniProt: P12318,---,(C;T) / (T;T),H allelle (rs1801274),Effect Directly Studied,Patients with this genotype may have increased progression-free survival time when using cetuximab to treat colorectal cancer.,BLA125084
4,DB00002,Cetuximab,Cetuximab,Low affinity immunoglobulin gamma Fc region receptor III-AGene symbol: FCGR3AUniProt: P08637,---,(G;T) / (T;T),G > T (rs396991),Effect Directly Studied,Patients with this genotype have increased progression-free survival time when using cetuximab to treat colorectal cancer.,BLA125084
5,DB04868,Nilotinib,Nilotinib,UDP-glucuronosyltransferase 1-1Gene symbol: UGT1A1UniProt: P22309,UGT1A1*28 or UGT1A 7/7,Not Available,extra TA in promoter (rs8175347),ADR Directly Studied,Patients who carry this polymorphism in UGT1A1 are at a higer risk of developing hyperbilirubinemia when treated with nilotinib.,NDA022068
6,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Villeurbanne,Not Available,1000_1002delACC,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
7,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Torun,Not Available,1006A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
8,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Sunderland,Not Available,105_107delCAT,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
9,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Iwatsuki,Not Available,1081G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
10,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Serres,Not Available,1082C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
11,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Tondela,Not Available,1084_1101delCTGAACGAGCGCAAGGCC,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
12,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Loma Linda,Not Available,1089C->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
13,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Aachen,Not Available,1089C->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
14,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Tenri,Not Available,1096A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
15,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Montpellier,Not Available,1132G>A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
16,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Calvo Mackenna,Not Available,1138A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
17,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Riley,Not Available,1139T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
18,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Olomouc,Not Available,1141T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
19,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Tomah,Not Available,1153T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
20,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Lynwood,Not Available,1154G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
21,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Madrid,Not Available,1155C->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
22,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Iowa, Walter Reed, Springfield",Not Available,1156A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
23,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Beverly Hills, Genova, Iwate, Niigata, Yamaguchi",Not Available,1160G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
24,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Hartford,Not Available,1162A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
25,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Praha,Not Available,1166A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
26,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Krakow,Not Available,1175T>C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
27,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Wisconsin,Not Available,1177C->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
28,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Nashville, Anaheim, Portici",Not Available,1178G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
29,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Alhambra,Not Available,1180G->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
30,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Bari,Not Available,1187C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
31,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Puerto Limon,Not Available,1192G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
32,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Covao do Lobo,Not Available,1205C>A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
33,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Clinic,Not Available,1215G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
34,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Utrecht,Not Available,1225C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
35,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Suwalki,Not Available,1226C->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
36,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Riverside,Not Available,1228G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
37,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Japan, Shinagawa",Not Available,1229G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
38,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Kawasaki,Not Available,1229G->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
39,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Munich,Not Available,1231A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
40,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Georgia,Not Available,1284C->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
41,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Sumare,Not Available,1292T->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
42,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Telti/Kobe,Not Available,1318C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
43,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Santiago de Cuba, Morioka",Not Available,1339G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
44,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Harima,Not Available,1358T->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
45,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Figuera da Foz,Not Available,1366G->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
46,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Amiens,Not Available,1367A>T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
47,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Bangkok Noi,Not Available,"1376G->T, 1502T->G",ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
48,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Fukaya,Not Available,1462G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
49,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Campinas,Not Available,1463G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
50,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Buenos Aires,Not Available,1465C>T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
51,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Arakawa,Not Available,1466C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
52,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Brighton,Not Available,1488_1490delGAA,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
53,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Kozukata,Not Available,159G->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
54,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Amsterdam,Not Available,180_182delTCT,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
55,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,No name,Not Available,"202G->A, 376A->G, 1264C>G",ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
56,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Swansea,Not Available,224T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
57,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Urayasu,Not Available,281_283delAGA,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
58,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Vancouver,Not Available,317C->G544C->T592C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
59,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Mt Sinai,Not Available,"376A->G, 1159C->T",ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
60,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Plymouth,Not Available,488G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
61,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Volendam,Not Available,514C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
62,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Shinshu,Not Available,527A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
63,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Chikugo,Not Available,535A->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
64,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Tsukui,Not Available,561_563delCTC,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
65,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Pedoplis-Ckaro,Not Available,573C>G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
66,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Santiago,Not Available,593G->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
67,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Minnesota, Marion, Gastonia, LeJeune",Not Available,637G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
68,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Cincinnati,Not Available,"637G->T, 1037A->T",ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
69,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Harilaou,Not Available,648T->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
70,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,North Dallas,Not Available,683_685delACA,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
71,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Asahikawa,Not Available,695G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
72,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Durham,Not Available,713A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
73,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Stonybrook,Not Available,724_729delGGCACT,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
74,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Wayne,Not Available,769C->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
75,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Aveiro,Not Available,806G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
76,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Cleveland Corum,Not Available,820G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
77,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Lille,Not Available,821A>T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
78,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Bangkok,Not Available,825G>C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
79,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Sugao,Not Available,826C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
80,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,La Jolla,Not Available,832T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
81,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Wexham,Not Available,833C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
82,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Piotrkow,Not Available,851T>C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
83,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,West Virginia,Not Available,910G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
84,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Omiya,Not Available,921G->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
85,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Nara,Not Available,953_976delCCACCAAAGGGTACCTGGAC GACC,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
86,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Manhattan,Not Available,962G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
87,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Rehevot,Not Available,964T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
88,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Honiara,Not Available,99A->G 1360C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
89,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Tokyo, Fukushima",Not Available,1246G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
90,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Chatham,Not Available,1003G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
91,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Fushan,Not Available,1004C->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
92,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Partenope,Not Available,1052G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
93,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Ierapetra,Not Available,1057C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
94,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Anadia,Not Available,1193A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
95,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Abeno,Not Available,1220A->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
96,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Surabaya,Not Available,1291G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
97,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Pawnee,Not Available,1316G->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
98,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,S. Antioco,Not Available,1342A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
99,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Cassano,Not Available,1347G->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
100,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Hermoupolis,Not Available,1347G->C 1360C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
101,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Union,Maewo, Chinese-2, Kalo",Not Available,1360C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
102,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Andalus,Not Available,1361G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
103,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Cosenza,Not Available,1376G->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
104,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Canton, Taiwan- Hakka, Gifu-like, Agrigento-like",Not Available,1376G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
105,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Flores,Not Available,1387C->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
106,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Kaiping, Anant, Dhon, Sapporo-like, Wosera",Not Available,1388G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
107,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Kamogawa,Not Available,169C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
108,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Costanzo,Not Available,179T>C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
109,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Amazonia,Not Available,185C->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
110,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Songklanagarind,Not Available,196T->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
111,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Hechi,Not Available,202G->A 871G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
112,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Namouru,Not Available,208T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
113,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Bao Loc,Not Available,352T>C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
114,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Crispim,Not Available,"375G->T, 379G->T383T->C384C>T",ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
115,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Acrokorinthos,Not Available,376A->G 463C->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
116,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Santa Maria,Not Available,376A->G 542A->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
117,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Ananindeua,Not Available,376A->G 871G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
118,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Vanua Lava,Not Available,383T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
119,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Valladolid,Not Available,406C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
120,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Belem,Not Available,409C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
121,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Liuzhou,Not Available,442G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
122,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Shenzen,Not Available,473G>A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
123,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Taipei ‚ÄúChinese- 3‚Äù,Not Available,493A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
124,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Toledo,Not Available,496C>T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
125,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Naone,Not Available,497G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
126,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Nankang,Not Available,517T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
127,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Miaoli,Not Available,519C->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
128,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Mediterranean, Dallas, Panama‚ Sassari, Cagliari, Birmingham",Not Available,563C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
129,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Coimbra Shunde,Not Available,592C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
130,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Nilgiri,Not Available,593G>A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
131,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Radlowo,Not Available,679C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
132,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Roubaix,Not Available,811G>C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
133,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Haikou,Not Available,835A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
134,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Chinese-1,Not Available,835A->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
135,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Mizushima,Not Available,848A>G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
136,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Osaka,Not Available,853C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
137,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Viangchan, Jammu",Not Available,871G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
138,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Seoul,Not Available,916G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
139,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Ludhiana,Not Available,929G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
140,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Farroupilha,Not Available,977C->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
141,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Chinese-5,Not Available,1024C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
142,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Rignano,Not Available,130G>A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
143,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Orissa,Not Available,131C->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
144,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,G6PDNice,Not Available,1380G>C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
145,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Kamiube, Keelung",Not Available,1387C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
146,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Neapolis,Not Available,1400C->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
147,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Aures,Not Available,143T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
148,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Split,Not Available,1442C->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
149,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Kambos,Not Available,148C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
150,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Palestrina,Not Available,170G>A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
151,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Metaponto,Not Available,172G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
152,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Musashino,Not Available,185C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
153,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Asahi,Not Available,202G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
154,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"A- (202), Ferrara I",Not Available,202G->A 376A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
155,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Murcia Oristano,Not Available,209A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
156,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Ube Konan,Not Available,241C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
157,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Lagosanto,Not Available,242G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
158,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Guangzhou,Not Available,274C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
159,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Hammersmith,Not Available,323T->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
160,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Sinnai,Not Available,34G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
161,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,A- (680),Not Available,376A->G 680G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
162,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"A- (968), Betica,Selma, Guantanamo",Not Available,376A->G 968T->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
163,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Salerno Pyrgos,Not Available,383T>G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
164,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Quing Yan,Not Available,392G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
165,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Lages,Not Available,40G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
166,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Ilesha,Not Available,466G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
167,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Mahidol,Not Available,487G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
168,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Malaga,Not Available,542A->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
169,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Sibari,Not Available,634A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
170,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Mexico City,Not Available,680G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
171,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Nanning,Not Available,703C->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
172,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Seattle, Lodi, Modena, Ferrara II, Athens-like",Not Available,844G->C,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
173,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Bajo Maumere,Not Available,844G->T,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
174,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Montalbano,Not Available,854G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
175,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,"Kalyan-Kerala, Jamnaga, Rohini",Not Available,949G->A,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
176,DB08912,Dabrafenib,Dabrafenib,Glucose-6-phosphate 1-dehydrogenaseGene symbol: G6PDUniProt: P11413,Gaohe,Not Available,95A->G,ADR Inferred,Increased risk of hemolytic anemia.,NDA202806
177,DB00317,Gefitinib,Gefitinib,ATP-binding cassette sub-family G member 2Gene symbol: ABCG2UniProt: Q9UNQ0,---,(A;C),A allele (rs2231142),ADR Directly Studied,Patients with this genotype have an increased risk of diarrhea with gefitinib.,NDA206995
178,DB00317,Gefitinib,Gefitinib,Epidermal growth factor receptorGene symbol: EGFRUniProt: P00533,L858R,(G;G) / (G;T),T > G (rs121434568),Effect Directly Studied,The presence of this polymorphism in EGFR is associated with a higher response rate to gefitinib.,NDA206995
179,DB00317,Gefitinib,Gefitinib,Epidermal growth factor receptorGene symbol: EGFRUniProt: P00533,G719A/C,(A;A) / (A;G) / (C;C) / (C;G) / (G;T) / (T;T),G > A or C or T (rs28929495),Effect Directly Studied,The presence of this polymorphism in EGFR is associated with a higher response rate to gefitinib.,NDA206995
180,DB00317,Gefitinib,Gefitinib,Epidermal growth factor receptorGene symbol: EGFRUniProt: P00533,L861Q,(A;A) / (A;T) / (G;G) / (G;T),T > A or G (rs121913444),Effect Directly Studied,The presence of this polymorphism in EGFR is associated with a higher response rate to gefitinib.,NDA206995
181,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*3,Not Available,C allele (rs35742686),Effect Inferred,Poor drug metabolizer.,NDA206995
182,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*4,Not Available,C allele (rs3892097),Effect Inferred,Poor drug metabolizer.,NDA206995
183,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*5,Not Available,Whole-gene deletion,Effect Inferred,Poor drug metabolizer.,NDA206995
184,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*6,Not Available,1707delT (rs5030655),Effect Inferred,Poor drug metabolizer.,NDA206995
185,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*7,Not Available,2935A>C (rs5030867),Effect Inferred,Poor drug metabolizer.,NDA206995
186,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*8,Not Available,1758G>T (rs5030865),Effect Inferred,Poor drug metabolizer.,NDA206995
187,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*11,Not Available,883G>C (rs5030863),Effect Inferred,Poor drug metabolizer.,NDA206995
188,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*12,Not Available,124G>A (rs5030862),Effect Inferred,Poor drug metabolizer.,NDA206995
189,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*13,Not Available,CYP2D7/2D6 hybrid gene structure,Effect Inferred,Poor drug metabolizer.,NDA206995
190,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*14A,Not Available,1758G>A (rs5030865),Effect Inferred,Poor drug metabolizer.,NDA206995
191,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*15,Not Available,"137insT, 137_138insT",Effect Inferred,Poor drug metabolizer.,NDA206995
192,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*19,Not Available,2539_2542delAACT (rs72549353),Effect Inferred,Poor drug metabolizer.,NDA206995
193,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*20,Not Available,1973_1974insG (rs72549354),Effect Inferred,Poor drug metabolizer.,NDA206995
194,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*21,Not Available,2573insC,Effect Inferred,Poor drug metabolizer.,NDA206995
195,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*31,Not Available,-1770G>A -1584C>G -1235A>Gshow all 17 …,Effect Inferred,Poor drug metabolizer.,NDA206995
196,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*36,Not Available,100C>T (rs1065852) -1426C>T variable number of A’s in the region -1258 to -1237ashow all 9 …,Effect Inferred,Poor drug metabolizer.,NDA206995
197,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*38,Not Available,2587_2590delGACT (rs72549351),Effect Inferred,Poor drug metabolizer.,NDA206995
198,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*40,Not Available,1863_1864ins(TTT CGC CCC)2 (rs72549356),Effect Inferred,Poor drug metabolizer.,NDA206995
199,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*42,Not Available,3259_3260insGT (rs72549346),Effect Inferred,Poor drug metabolizer.,NDA206995
200,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*44,Not Available,2950G>C,Effect Inferred,Poor drug metabolizer.,NDA206995
201,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*47,Not Available,100C>T (rs1065852) -1426C>T -1235A>Gshow all 8 …,Effect Inferred,Poor drug metabolizer.,NDA206995
202,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*51,Not Available,-1584C>G -1235A>G -740C>Tshow all 9 …,Effect Inferred,Poor drug metabolizer.,NDA206995
203,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*56,Not Available,3201C>T (rs72549347),Effect Inferred,Poor drug metabolizer.,NDA206995
204,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*57,Not Available,100C>T 310G>T 843T>Gshow all 10 …,Effect Inferred,Poor drug metabolizer.,NDA206995
205,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*62,Not Available,4044C>T,Effect Inferred,Poor drug metabolizer.,NDA206995
206,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*68A,Not Available,-1426C>T -1235A>G -1000G>Ashow all 6 …,Effect Inferred,Poor drug metabolizer.,NDA206995
207,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*68B,Not Available,Similar but not identical switch region compared to CYP2D6*68A. Found in tandem arrangement with CYP2D6*4.,Effect Inferred,Poor drug metabolizer.,NDA206995
208,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*69,Not Available,2988G>A (rs28371725) -1426C>T -1235A>Gshow all 17 …,Effect Inferred,Poor drug metabolizer.,NDA206995
209,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*92,Not Available,1995delC,Effect Inferred,Poor drug metabolizer.,NDA206995
210,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*100,Not Available,-1426C>T -1235A>G -1109C>Tshow all 15 …,Effect Inferred,Poor drug metabolizer.,NDA206995
211,DB00317,Gefitinib,Gefitinib,Cytochrome P450 2D6Gene symbol: CYP2D6UniProt: P10635,CYP2D6*101,Not Available,-1426C>T -1235A>G -1000G>Ashow all 14 …,Effect Inferred,Poor drug metabolizer.,NDA206995
212,DB08916,Afatinib,Afatinib,Epidermal growth factor receptorGene symbol: EGFRUniProt: P00533,L861Q,(A;A) / (A;T) / (G;G) / (G;T),T > A or G (rs121913444),Effect Directly Studied,The presence of this polymorphism in EGFR is associated with a higher response rate to afatinib.,NDA201292
213,DB08916,Afatinib,Afatinib,Epidermal growth factor receptorGene symbol: EGFRUniProt: P00533,L858R,(G;G) / (G;T),T > G (rs121434568),Effect Directly Studied,The presence of this polymorphism in EGFR is associated with a higher response rate to afatinib.,NDA201292
214,DB08916,Afatinib,Afatinib,Epidermal growth factor receptorGene symbol: EGFRUniProt: P00533,G719A/C,(A;A) / (A;G) / (C;C) / (C;G) / (G;T) / (T;T),G > A or C or T (rs28929495),Effect Directly Studied,The presence of this polymorphism in EGFR is associated with a higher response rate to afatinib.,NDA201292
215,DB00072,Trastuzumab,Trastuzumab,Receptor tyrosine-protein kinase erbB-2Gene symbol: ERBB2UniProt: P04626,---,(A;G),"G Allele, heterozygote (rs1136201)",ADR Directly Studied,Patients with this genotype have increased risk of cardiotoxicity with trastuzumab.,BLA103792
